« Back
Home /
MLN8054

MLN8054

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Amount	100 mg
Item no.	HY-10180-100mg
Targets	Aurora Kinase
CASRN	869363-13-3
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	MLN8054 is a potent, selective and orally available aurora A kinase inhibitor with an IC50 of 4 nM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	476.86
Clinical_Information	Phase 1
Manufacturers Research_Area	Cancer
Solubility	DMSO : 20.83 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target	Aurora Kinase
Isoform	Aurora A
Pathway	Cell Cycle/DNA Damage; Epigenetics
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-10180-100mg-safety-datasheet.pdf